Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
durvalumab
×
Other solid neoplasm
×
Clear all
Filters
3
NCT04334759
2026-01-22
DREAM3R
PrECOG, LLC.
Phase 3
Completed
214 enrolled